Darvon and Darvocet


Darvon® and Darvocet® Removed from Market

Xanodyne Pharmaceuticals, Inc., the maker of the painkiller drugs Darvon® and Darvocet®, has withdrawn these medications from the U.S. market at the request of the FDA.

Why are Darvon and Darvocet considered dangerous?

Darvon and Darvocet contain a chemical known as propoxyphene, which is an opioid used to treat mild to moderate pain. It was first approved by the FDA in 1957 and is sold by prescription under various names alone (e.g., Darvon), or in combination with acetaminophen (e.g., Darvocet). Propoxyphene, however, has been linked to serious heart problems.

What is being done to protect consumers?

The FDA has requested that every drug company remove all products containing propoxyphene from the market. According to the FDA, clinical data suggested the drugs put patients at an increased risk for serious or potentially life-threatening heart rhythm abnormalities.

As a result of this data, along with other information, the FDA found that the risks posed by propoxyphene outweighed its pain management benefits.

What symptoms are associated with Darvon or Darvocet use?

The adverse symptoms of Darvon or Darvocet use include:

  • heart failure
  • heart attack
  • sudden cardiac death

We Want to Help

Our law firm is reviewing cases for which objective diagnostic test reports and records are available to document a patient was taking the drug at the time of suffering heart failure, heart attack, or sudden cardiac death. We are also reviewing cases in which individuals suffered hip fracture while taking Darvon, Darvocet, or a propoxyphene-containing drug.

If you or a loved one have suffered serious side effects, or your loved one has died from the use a dangerous drug, you may be able to file a dangerous drug claim. Contact DeMayo Law Offices, L.L.P. ® to schedule your free initial consultation.

Darvocet and Darvon are registered trademarks of Xanodyne Pharmaceuticals, Inc., and are only used here to identify the products in question. This law firm is not associated with, sponsored by, or affiliated with the Food and Drug Administration or Xanodyne Pharmaceuticals, Inc.

Office Locations

With North Carolina office locations in Charlotte, Hickory, Monroe and in Columbia, South Carolina, DeMayo Law Offices have been serving the state since 1992. You can contact us 24/7 and if you are unable to come to us - we will come to you.


FREE CASE EVALAUATION

Provide the below information and we will contact you.

  • This field is for validation purposes and should be left unchanged.
Phone icon
Call Us 24/7
Location icon
Convenient
Locations
home icon
We Come
To You

Please do not include any confidential or sensitive information in this form. This form sends information by non-encrypted email which is not secure. Submitting this form does not create an attorney-client relationship.




Member of the Multi-Million Dollar Advocates Forum Member of the Million Dollar Advocates Forum Top 100 Trial Lawyers North Carolina Advocates for Justice
AV Preeminent Client Champion The Law Offices of Michael A. DeMayo is a BBB Accredited Business Rated by Super Lawyers

Membership in the Million Dollar Advocates Forum is limited to attorneys who have won million and multi-million dollar verdicts and settlements. Criteria for membership in Million Dollar Advocates can be found by clicking here. DeMayo Law Offices, L.L.P. does not represent that similar results will be achieved in your case. Each case is different and must be evaluated separately.

The National Trial Lawyers is a national organization composed of the Top 100 Trial Lawyers from each state. Membership is obtained through special invitation and is extended only to those attorneys who exemplify superior qualifications, leadership, reputation, influence, stature, and profile as trial lawyers, both civil plaintiff and criminal defense. More information can be found at the National Trial Lawyers web site by clicking here. DeMayo Law Offices, L.L.P. does not represent that similar results will be achieved in your case. Each case is different and must be evaluated separately.